Fresenius Historical Income Statement

FMS Stock

USD 24.62 0.16 0.65%

Historical analysis of Fresenius Medical income statement accounts such as Gross Profit of 3.8 B or Operating Income of 1.4 B can show how well Fresenius Medical Care performed in making a profits. Evaluating Fresenius Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Fresenius Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Fresenius Medical Care latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fresenius Medical Care is a good buy for the upcoming year.

Net Income Gross Profit

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

About Fresenius Income Statement Analysis

Fresenius Medical Care Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Fresenius Medical shareholders. The income statement also shows Fresenius investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Fresenius Medical Income Statement Chart

At this time, Fresenius Medical's EBIT is comparatively stable compared to the past year. Net Income is likely to gain to about 708.2 M in 2025, whereas Total Revenue is likely to drop slightly above 11.7 B in 2025.

Total Revenue Gross Profit Ebitda Net Income

Total Revenue

Total revenue comprises all receipts Fresenius Medical Care generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Fresenius Medical Care minus its cost of goods sold. It is profit before Fresenius Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Fresenius Medical Care financial statement analysis. It represents the amount of money remaining after all of Fresenius Medical Care operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most accounts from Fresenius Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Fresenius Medical Care current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

	2022	2023	2024	2025 (projected)
Gross Profit	5.3B	4.9B	4.8B	3.8B
Total Revenue	19.4B	19.5B	19.3B	11.7B

Gross Profit Total Revenue

Fresenius Medical income statement Correlations

	Interest Expense	Total Revenue	Gross Profit	Operating Income	Ebit	Ebitda	Net Income	Income Tax Expense	Depreciation And Amortization	Selling General Administrative	Other Operating Expenses	Research Development	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Minority Interest	Net Income From Continuing Ops	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Selling And Marketing Expenses
Interest Expense		0.82	0.72	-0.22	-0.25	0.17	0.64	0.77	0.31	0.69	0.77	0.59	0.78	0.7	0.74	0.33	0.49	0.26	-0.15	0.06	0.05	0.18	0.25
Total Revenue	0.82		0.89	-0.45	-0.36	0.33	0.42	0.45	0.68	0.87	1.0	0.91	0.99	0.97	0.52	-0.01	0.19	-0.05	-0.57	-0.33	0.45	0.57	0.13
Gross Profit	0.72	0.89		-0.25	-0.09	0.46	0.56	0.44	0.47	0.92	0.86	0.74	0.84	0.92	0.64	0.15	0.45	0.23	-0.34	-0.03	0.32	0.36	0.23
Operating Income	-0.22	-0.45	-0.25		0.72	0.16	0.17	0.01	-0.72	-0.46	-0.49	-0.67	-0.48	-0.48	0.12	0.31	0.32	0.52	0.61	0.36	-0.29	-0.8	0.07
Ebit	-0.25	-0.36	-0.09	0.72		0.67	0.16	0.04	-0.53	-0.33	-0.4	-0.45	-0.4	-0.38	0.14	-0.04	0.34	0.5	0.59	0.5	-0.18	-0.55	0.12
Ebitda	0.17	0.33	0.46	0.16	0.67		0.22	0.08	0.17	0.2	0.31	0.31	0.32	0.3	0.25	-0.19	0.27	0.21	-0.02	0.14	0.19	0.15	0.18
Net Income	0.64	0.42	0.56	0.17	0.16	0.22		0.71	-0.08	0.56	0.34	0.15	0.33	0.37	0.97	0.63	0.57	0.75	0.2	0.39	0.12	-0.22	0.17
Income Tax Expense	0.77	0.45	0.44	0.01	0.04	0.08	0.71		-0.08	0.49	0.37	0.19	0.38	0.34	0.83	0.25	0.56	0.47	0.33	0.3	-0.12	-0.23	0.11
Depreciation And Amortization	0.31	0.68	0.47	-0.72	-0.53	0.17	-0.08	-0.08		0.54	0.72	0.81	0.73	0.69	-0.03	-0.27	-0.26	-0.48	-0.88	-0.67	0.44	0.97	-0.4
Selling General Administrative	0.69	0.87	0.92	-0.46	-0.33	0.2	0.56	0.49	0.54		0.85	0.76	0.83	0.92	0.63	0.09	0.32	0.16	-0.42	-0.13	0.43	0.43	0.1
Other Operating Expenses	0.77	1.0	0.86	-0.49	-0.4	0.31	0.34	0.37	0.72	0.85		0.93	1.0	0.97	0.44	-0.06	0.12	-0.13	-0.63	-0.41	0.49	0.63	0.1
Research Development	0.59	0.91	0.74	-0.67	-0.45	0.31	0.15	0.19	0.81	0.76	0.93		0.93	0.9	0.24	-0.21	-0.06	-0.29	-0.7	-0.47	0.57	0.78	0.11
Cost Of Revenue	0.78	0.99	0.84	-0.48	-0.4	0.32	0.33	0.38	0.73	0.83	1.0	0.93		0.96	0.43	-0.06	0.11	-0.14	-0.63	-0.42	0.48	0.63	0.09
Total Operating Expenses	0.7	0.97	0.92	-0.48	-0.38	0.3	0.37	0.34	0.69	0.92	0.97	0.9	0.96		0.45	-0.05	0.16	-0.07	-0.62	-0.36	0.51	0.59	0.12
Income Before Tax	0.74	0.52	0.64	0.12	0.14	0.25	0.97	0.83	-0.03	0.63	0.44	0.24	0.43	0.45		0.53	0.63	0.71	0.21	0.36	0.09	-0.19	0.17
Total Other Income Expense Net	0.33	-0.01	0.15	0.31	-0.04	-0.19	0.63	0.25	-0.27	0.09	-0.06	-0.21	-0.06	-0.05	0.53		0.49	0.62	0.27	0.54	-0.34	-0.35	0.25
Minority Interest	0.49	0.19	0.45	0.32	0.34	0.27	0.57	0.56	-0.26	0.32	0.12	-0.06	0.11	0.16	0.63	0.49		0.82	0.45	0.58	-0.38	-0.35	0.27
Net Income From Continuing Ops	0.26	-0.05	0.23	0.52	0.5	0.21	0.75	0.47	-0.48	0.16	-0.13	-0.29	-0.14	-0.07	0.71	0.62	0.82		0.57	0.63	-0.14	-0.58	0.23
Tax Provision	-0.15	-0.57	-0.34	0.61	0.59	-0.02	0.2	0.33	-0.88	-0.42	-0.63	-0.7	-0.63	-0.62	0.21	0.27	0.45	0.57		0.77	-0.58	-0.86	0.36
Interest Income	0.06	-0.33	-0.03	0.36	0.5	0.14	0.39	0.3	-0.67	-0.13	-0.41	-0.47	-0.42	-0.36	0.36	0.54	0.58	0.63	0.77		-0.61	-0.64	0.52
Net Interest Income	0.05	0.45	0.32	-0.29	-0.18	0.19	0.12	-0.12	0.44	0.43	0.49	0.57	0.48	0.51	0.09	-0.34	-0.38	-0.14	-0.58	-0.61		0.41	-0.07
Reconciled Depreciation	0.18	0.57	0.36	-0.8	-0.55	0.15	-0.22	-0.23	0.97	0.43	0.63	0.78	0.63	0.59	-0.19	-0.35	-0.35	-0.58	-0.86	-0.64	0.41		-0.3
Selling And Marketing Expenses	0.25	0.13	0.23	0.07	0.12	0.18	0.17	0.11	-0.4	0.1	0.1	0.11	0.09	0.12	0.17	0.25	0.27	0.23	0.36	0.52	-0.07	-0.3

Click cells to compare fundamentals

Fresenius Medical Account Relationship Matchups

Fresenius Medical income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Interest Expense	410M	353M	360M	424.6M	407.0M	246.0M
Total Revenue	17.9B	17.6B	19.4B	19.5B	19.3B	11.7B
Gross Profit	5.5B	5.1B	5.3B	4.9B	4.8B	3.8B
Operating Income	529M	301.3M	(258.4M)	1.4B	1.4B	1.4B
Ebit	2.5B	2.0B	(140.1M)	1.5B	1.5B	1.5B
Ebitda	4.1B	3.5B	1.6B	3.2B	3.2B	2.3B
Net Income	1.2B	969.3M	673.4M	499.0M	537.9M	708.2M
Income Tax Expense	501M	353M	325M	300.6M	316.1M	357.4M
Depreciation And Amortization	1.6B	1.6B	1.7B	1.8B	1.7B	1.8B
Selling General Administrative	3.2B	3.1B	3.8B	2.4B	2.4B	2.2B
Other Operating Expenses	15.7B	15.9B	18.1B	18.1B	17.9B	10.6B
Research Development	194M	221M	229M	232.0M	183.5M	110.6M
Cost Of Revenue	12.3B	12.5B	14.1B	14.5B	14.6B	8.3B
Total Operating Expenses	3.4B	3.3B	4.0B	3.6B	3.4B	2.3B
Income Before Tax	1.9B	1.6B	1.2B	1.0B	1.1B	1.2B
Total Other Income Expense Net	(368.0M)	(280.4M)	(292.5M)	(336.4M)	(335.5M)	(318.7M)
Net Income Applicable To Common Shares	1.2B	1.2B	969.3M	673.4M	774.4M	931.7M
Minority Interest	1.1B	(250M)	(222M)	(233.5M)	(203.0M)	(192.8M)
Net Income From Continuing Ops	1.4B	1.2B	895M	732.5M	740.9M	1.1B
Tax Provision	501M	353M	325M	300.6M	316.1M	347.3M
Interest Income	368M	280M	68M	88.2M	71.6M	68.0M
Net Interest Income	(368.0M)	(280M)	(292M)	(336.4M)	(335.5M)	(352.2M)
Reconciled Depreciation	1.8B	1.6B	1.8B	1.8B	1.7B	1.6B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Fresenius Historical Income Statement

About Fresenius Income Statement Analysis

Fresenius Medical Income Statement Chart

Total Revenue

Gross Profit

Net Income

Fresenius Medical income statement Correlations

Fresenius Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Fresenius Medical income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Fresenius Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Other Operating Expenses
Cost Of Revenue	+ 0.99	Total Revenue
Total Operating Expenses	+ 0.97	Total Revenue
Income Before Tax	+ 0.97	Net Income
Reconciled Depreciation	+ 0.97	Depreciation And Amortization

Tax Provision	- 0.88	Depreciation And Amortization
Reconciled Depreciation	- 0.86	Tax Provision
Reconciled Depreciation	- 0.8	Operating Income
Depreciation And Amortization	- 0.72	Operating Income
Tax Provision	- 0.7	Research Development
Interest Income	- 0.67	Depreciation And Amortization